Birdwatch Note
2025-06-06 13:06:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Remdesivir did not increase risk of death from Ebola, but it was inferior to other studied treatments in the treatment of Ebola. About 53% of patients receiving remdesivir died from Ebola in the trial compared to 35% with the superior therapeutics. https://www.nih.gov/news-events/news-releases/investigational-drugs-reduce-risk-death-ebola-virus-disease https://pmc.ncbi.nlm.nih.gov/articles/PMC7250494
Written by C2185745E8EE3B84EC386DECA4A20F54926A6ADC8CE75F38E7D6C18AFCF58179
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1930898607768477767
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1930974457620771321
- noteId - 1930974457620771321
- participantId -
- noteAuthorParticipantId - C2185745E8EE3B84EC386DECA4A20F54926A6ADC8CE75F38E7D6C18AFCF58179
- createdAtMillis - 1749215161124
- tweetId - 1930898607768477767
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Remdesivir did not increase risk of death from Ebola, but it was inferior to other studied treatments in the treatment of Ebola. About 53% of patients receiving remdesivir died from Ebola in the trial compared to 35% with the superior therapeutics. https://www.nih.gov/news-events/news-releases/investigational-drugs-reduce-risk-death-ebola-virus-disease https://pmc.ncbi.nlm.nih.gov/articles/PMC7250494
Note Ratings
| rated at | rated by | |
| 2025-06-07 12:34:27 -0400 | Rating Details | |
| 2025-06-07 11:22:35 -0400 | Rating Details | |
| 2025-06-06 09:28:44 -0400 | Rating Details | |
| 2025-06-06 10:36:38 -0400 | Rating Details | |
| 2025-06-07 15:24:44 -0400 | Rating Details | |
| 2025-06-06 22:36:53 -0400 | Rating Details | |
| 2025-06-06 15:53:39 -0400 | Rating Details | |
| 2025-06-06 17:47:04 -0400 | Rating Details | |
| 2025-06-06 11:56:45 -0400 | Rating Details | |
| 2025-06-07 18:37:21 -0400 | Rating Details | |
| 2025-06-07 02:00:03 -0400 | Rating Details | |
| 2025-06-07 00:35:13 -0400 | Rating Details | |
| 2025-06-06 18:13:33 -0400 | Rating Details | |
| 2025-06-07 09:09:02 -0400 | Rating Details | |
| 2025-06-06 13:52:54 -0400 | Rating Details | |
| 2025-06-07 22:31:59 -0400 | Rating Details | |
| 2025-06-07 22:29:22 -0400 | Rating Details | |
| 2025-06-06 14:03:46 -0400 | Rating Details | |
| 2025-06-06 12:41:37 -0400 | Rating Details | |
| 2025-06-06 11:51:46 -0400 | Rating Details | |
| 2025-06-06 10:46:52 -0400 | Rating Details | |
| 2025-06-06 23:27:11 -0400 | Rating Details | |
| 2025-06-06 23:05:02 -0400 | Rating Details | |
| 2025-06-06 22:42:09 -0400 | Rating Details | |
| 2025-06-06 12:33:48 -0400 | Rating Details | |
| 2025-06-06 11:48:13 -0400 | Rating Details | |
| 2025-06-06 10:43:57 -0400 | Rating Details | |
| 2025-06-06 11:56:44 -0400 | Rating Details | |
| 2025-06-08 13:07:40 -0400 | Rating Details | |
| 2025-06-06 22:44:22 -0400 | Rating Details | |
| 2025-06-06 09:37:21 -0400 | Rating Details | |
| 2025-06-06 09:32:58 -0400 | Rating Details | |
| 2025-06-09 18:27:45 -0400 | Rating Details | |
| 2025-06-07 09:34:09 -0400 | Rating Details | |
| 2025-06-06 11:38:42 -0400 | Rating Details | |
| 2025-06-07 16:00:54 -0400 | Rating Details | |
| 2025-06-07 04:05:40 -0400 | Rating Details | |
| 2025-06-07 02:52:29 -0400 | Rating Details | |
| 2025-06-06 12:43:05 -0400 | Rating Details |